NL192387C - Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat. - Google Patents

Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat. Download PDF

Info

Publication number
NL192387C
NL192387C NL8503171A NL8503171A NL192387C NL 192387 C NL192387 C NL 192387C NL 8503171 A NL8503171 A NL 8503171A NL 8503171 A NL8503171 A NL 8503171A NL 192387 C NL192387 C NL 192387C
Authority
NL
Netherlands
Prior art keywords
formula
derivatives
ethanol
ethyl acetate
silibinine
Prior art date
Application number
NL8503171A
Other languages
English (en)
Dutch (nl)
Other versions
NL192387B (nl
NL8503171A (nl
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus Ag filed Critical Madaus Ag
Publication of NL8503171A publication Critical patent/NL8503171A/nl
Publication of NL192387B publication Critical patent/NL192387B/xx
Application granted granted Critical
Publication of NL192387C publication Critical patent/NL192387C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
NL8503171A 1984-11-22 1985-11-18 Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat. NL192387C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3442639 1984-11-22
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (3)

Publication Number Publication Date
NL8503171A NL8503171A (nl) 1986-06-16
NL192387B NL192387B (nl) 1997-03-03
NL192387C true NL192387C (nl) 1997-07-04

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8503171A NL192387C (nl) 1984-11-22 1985-11-18 Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat.

Country Status (29)

Country Link
JP (1) JPS61143377A (fr)
KR (1) KR870001020B1 (fr)
AR (1) AR240931A1 (fr)
AT (1) AT393268B (fr)
BE (1) BE903693A (fr)
CA (1) CA1337124C (fr)
CH (1) CH659473A5 (fr)
CS (1) CS273610B2 (fr)
DD (1) DD259191A1 (fr)
DE (1) DE3442639A1 (fr)
DK (1) DK164865C (fr)
EG (1) EG19424A (fr)
ES (1) ES8609311A1 (fr)
FI (1) FI84064C (fr)
FR (1) FR2573427B1 (fr)
GB (1) GB2167414B (fr)
HU (1) HU195503B (fr)
IE (1) IE58791B1 (fr)
IT (1) IT1190426B (fr)
LU (1) LU86163A1 (fr)
MX (1) MX168415B (fr)
NL (1) NL192387C (fr)
NO (1) NO160205C (fr)
PL (1) PL146890B1 (fr)
PT (1) PT81532B (fr)
SE (1) SE465676B (fr)
SU (1) SU1436875A3 (fr)
YU (1) YU43689B (fr)
ZA (1) ZA858951B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
RU2431634C2 (ru) * 2005-03-11 2011-10-20 Говард Флори Инститьют Оф Експериментл Физиолоджи Энд Медсин Соединения флавоноидов и их применение
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
PT2219642E (pt) * 2007-11-15 2011-10-18 Madaus Gmbh Componente de silibinina para o tratamento de hepatite
PT2430017T (pt) 2009-05-14 2016-10-12 Madaus Gmbh Método para a preparação de silibinina amorfa
CN104427981B (zh) 2012-07-05 2018-05-25 纽崔玛氏科技有限责任公司 包含莱菔硫烷或莱菔硫烷前体和蕈类提取物或粉末的组合物
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
CA1337124C (fr) 1995-09-26
DE3442639A1 (de) 1986-05-22
DK537785D0 (da) 1985-11-21
SE8505487L (sv) 1986-05-23
YU43689B (en) 1989-10-31
PT81532A (de) 1985-12-01
GB8528226D0 (en) 1985-12-18
HU195503B (en) 1988-05-30
ZA858951B (en) 1986-08-27
AR240931A1 (es) 1991-03-27
FI854535A0 (fi) 1985-11-18
SU1436875A3 (ru) 1988-11-07
FR2573427B1 (fr) 1989-03-10
NO160205C (no) 1989-03-22
MX168415B (es) 1993-05-24
JPS61143377A (ja) 1986-07-01
JPH0432073B2 (fr) 1992-05-28
IT8522932A0 (it) 1985-11-21
KR860004056A (ko) 1986-06-16
LU86163A1 (de) 1986-03-24
DK164865B (da) 1992-08-31
IT1190426B (it) 1988-02-16
FR2573427A1 (fr) 1986-05-23
YU178685A (en) 1988-02-29
PL256374A1 (en) 1986-12-02
DD259191A1 (de) 1988-08-17
CS273610B2 (en) 1991-03-12
HUT40114A (en) 1986-11-28
IE852808L (en) 1986-05-22
SE8505487D0 (sv) 1985-11-20
ES549116A0 (es) 1986-09-01
DK537785A (da) 1986-05-23
EG19424A (en) 1995-02-28
NL192387B (nl) 1997-03-03
GB2167414A (en) 1986-05-29
CH659473A5 (de) 1987-01-30
DK164865C (da) 1993-01-18
FI854535A (fi) 1986-05-23
AR240931A2 (es) 1991-03-27
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
BE903693A (fr) 1986-05-22
FI84064B (fi) 1991-06-28
PT81532B (pt) 1987-11-11
NO160205B (no) 1988-12-12
ATA337185A (de) 1991-02-15
FI84064C (fi) 1991-10-10
ES8609311A1 (es) 1986-09-01
NL8503171A (nl) 1986-06-16
AT393268B (de) 1991-09-25
DE3442639C2 (fr) 1989-08-10
KR870001020B1 (ko) 1987-05-23
CS837885A2 (en) 1990-08-14
NO854655L (no) 1986-05-23
IE58791B1 (en) 1993-11-17
GB2167414B (en) 1989-01-11

Similar Documents

Publication Publication Date Title
US4764508A (en) Complexes of flavanolignans with phospholipids, preparation thereof and associated pharmaceutical compositions
EP0275224B1 (fr) Complexes phospholipidiques d'extraits de Vitis vinifera, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
NL192387C (nl) Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat.
EP1161946A2 (fr) Analogues solubles du Probucol
KR0134376B1 (ko) 면역 억제제로서 유용한 4-퀴놀린 카르복실산 유도체
US3988446A (en) Glycerides with anti-inflammatory properties
US5202313A (en) Bilobalide derivatives, their applications and formulations containing them
KR20090033405A (ko) 알콜 및 케톤 및/또는 에스테르의 혼합물인 유기 용매에 아토르바스타틴 헤미-칼슘 염을 용해시키고 용매를 제거하여 비결정형 아토르바스타틴 헤미-칼슘을 제조하는 방법
CA2355776C (fr) Complexes phospholipidiques de proanthocyanidine a2 comme agents anti-atherosclereux
EP1153010A1 (fr) ACIDES AMINES $i(N) SUBSTITUES, COMPOSITIONS PHARMACEUTIQUES ANTI OXYDANTES LES CONTENANT ET PROCEDES D'UTILISATION DE CES DERNIERES
JP3032599B2 (ja) 長鎖カルボン酸マレイミド
SI8511786A8 (sl) Postopek za pripravo derivatov silibinina
CH665642A5 (fr) Derives de l'aminomethyle-6 furo-(3,4-c)-pyridine, leur preparation et compositions therapeutiques en contenant.
JPH0366685A (ja) イミダゾール誘導体及びそれを有効成分として含有する肝臓疾患治療薬
WO2000049030A1 (fr) Derives de 5-fluorouridine et anticancereux renfermant ces derives comme principe actif

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: MADAUS AKTIENGESELLSCHAFT

V1 Lapsed because of non-payment of the annual fee

Effective date: 20020601